Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study
Authors
Keywords
-
Journal
BMC Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-17
DOI
10.1186/s12916-020-01548-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada
- (2019) J. Smith-Palmer et al. BMC Urology
- A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
- (2019) Indu Kohaar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
- (2019) Daniël Osses et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NICE guidelines on prostate cancer 2019
- (2019) Prokar Dasgupta et al. BJU INTERNATIONAL
- Let's Keep It at One Step at a Time: Why Biparametric Magnetic Resonance Imaging Is Not the Priority Today
- (2019) Jochen Walz EUROPEAN UROLOGY
- Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
- (2019) Ivo G. Schoots et al. WORLD JOURNAL OF UROLOGY
- Prostate mpMRI in the UK: the state of the nation
- (2019) C. Davies et al. CLINICAL RADIOLOGY
- Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study
- (2019) Renata Zelic et al. EUROPEAN UROLOGY
- Developing an effective strategy to improve the detection of significant prostate cancer by combining the 4Kscore and multiparametric MRI
- (2019) Karim Marzouk et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting
- (2018) Mrishta Brizmohun Appayya et al. BJU INTERNATIONAL
- The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
- (2018) V. J. Gnanapragasam et al. BMC Medicine
- Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
- (2018) Henrik Grönberg et al. EUROPEAN UROLOGY
- Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis
- (2018) Niranjan J. Sathianathen et al. JOURNAL OF UROLOGY
- Cognitive Versus Software Fusion for MRI Targeted Biopsy: Experience Before and After Implementation of Fusion
- (2018) Steven M. Monda et al. UROLOGY
- Cost analysis of prostate cancer detection including the prostate health index (phi)
- (2018) Romain Mathieu et al. WORLD JOURNAL OF UROLOGY
- Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators
- (2018) Arnout R. Alberts et al. EUROPEAN UROLOGY
- Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
- (2018) Marloes van der Leest et al. EUROPEAN UROLOGY
- Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
- (2018) Olivier Rouvière et al. LANCET ONCOLOGY
- Early cost–effectiveness modeling for better decisions in public research investment of personalized medicine technologies
- (2018) Daphne I Ling et al. Journal of Comparative Effectiveness Research
- Reducing unnecessary biopsies while detecting clinically significant prostate cancer including cribriform growth with the ERSPC Rotterdam risk calculator and 4Kscore
- (2018) Jan F.M. Verbeek et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Abbreviated Biparametric Versus Standard Multiparametric MRI for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis
- (2018) Zhen Kang et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel
- (2017) Paul C. Moldovan et al. EUROPEAN UROLOGY
- A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
- (2017) Rianne J. Hendriks et al. PROSTATE
- Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer
- (2016) Stacy Loeb et al. BJU INTERNATIONAL
- The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index
- (2016) Eveline A.M. Heijnsdijk et al. VALUE IN HEALTH
- The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
- (2016) V. J. Gnanapragasam et al. Scientific Reports
- The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?
- (2014) Francesco Porpiglia et al. JOURNAL OF UROLOGY
- Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis
- (2014) Wenying Wang et al. Scientific Reports
- Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models
- (2013) Gian Maria Busetto et al. UROLOGY
- Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy
- (2012) Alessandro Sciarra et al. BJU INTERNATIONAL
- Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study
- (2012) Jennifer R. Rider et al. EUROPEAN UROLOGY
- Cost-effectiveness of Prostate Health Index for prostate cancer detection
- (2011) Michael B. Nichol et al. BJU INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started